Blog

Strong Evidence of Use (EoU) is a critical component in the successful monetization of a patent portfolio, buyers and licensees frequently base their decision on the presence of strong EoU.

Pelent’s Portfolio Analyzer provides an overall portfolio snapshot including Patent Rating metrics and a ‘floorplan’ visualization which allows users to hone into technology areas with the highest concentration of valuable patents.

While companies grapple with the chip shortage of 2022 there is no shortage of valuable patents at chip-designer Arm Limited. “Diamond” high value patents hold the potential to generate revenue through licensing or may be leveraged defensively if acquired by a practicing entity.

Pelent’s Portfolio checkup gives you crystal clear results about your patents almost immediately. Case in point: Proterra (NASDAQ: PTRA), which appears to be firing on all cylinders – or should we say all battery packs.

The terms patent value and patent quality are used interchangeably and are often confused and misunderstood. While one cannot completely divorce quality and value, it is important to understand the distinction.

Just how well are Canadian companies faring filing new patents? We ran an analysis of US granted patents for Canadian companies in the first half of 2022. The analysis sampled 530 granted patents from 263 companies (mostly SME’s) and university organizations.

We are pleased to announce that @Pelent is celebrating a remarkable milestone – our 7th anniversary! The journey has been incredible, marked by innovation and most importantly our client support.

Accounting for patents involves recognizing their cost, amortizing over their useful life, testing for impairment, and optionally revaluing them. A portfolio checkup allows accounting teams and portfolio managers to hone into low value assets and declare impaired patents as necessary.